Lonza expands Visp bioconjugation plans and updates scale to 3,000 liters
Company / institutional announcement · Lonza
Source published: · Event / reporting date: 2026-10-29
Site published: 2026-11-05 · Updated: 2026-11-05
This source is linked automatically. Choose a question to get started.
What changed
Lonza announced three planned multiproduct bioconjugation suites in Visp, with operations expected from 2028, alongside 500-liter single-use upgrades scheduled for 2027. A November 2 update revised the new facility's maximum scale from 1,200 to 3,000 liters. The capacity remains under development; the announcement does not establish available current commercial slots.
Why it may matter
Analysis: Planned scale flexibility may support ADC programs from development to commercialization; supply planning must account for construction and qualification milestones.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections